Posted inLife Science
Nucelion Pandorum Partnership: How Cell-Free Exosome Eye Therapies Are Made
The Nucelion Pandorum partnership pairs a cell-free eye-therapy developer with a GMP manufacturer. What exosomes are and what is unproven.
Posted inLife Science
Shamonda Virus Human Case Shows Why Livestock Surveillance Matters
The Shamonda virus human case in France is a One Health signal: a midge-borne cattle virus found in a person. What is known and what is not.
Posted inLife Science
AI in Drug Development: Discovery vs Operations Explained
AI in drug development explained: how discovery tools differ from tools that coordinate trials and risk, after OpenAI’s Orchestra Bio deal.
Posted inLife Science
AI in Clinical Trials: Can AstraZeneca and Oracle Fix Slow Recruitment?
AI in clinical trials explained: how AstraZeneca and Oracle plan to speed patient recruitment and safety monitoring, and what is unproven.
Posted inLife Science
LCA-0061 Food Allergy Drug: Early IgE Data, Real Limits
LCA-0061 food allergy drug explained: how Lycia’s IgE degrader works, what the early 96% IgE data show, and what they do not.
Posted inLife Science
Bipolar Mania Drug Research: How RAP-219 Targets AMPA Receptors
Bipolar mania drug research: how RAP-219 targets AMPA receptors, what the Phase 2 trial found, and what one trial cannot yet show.
Posted inLife Science
Solid Tumour Therapies Get a Promising Masked Engager Bet
Solid tumour therapies from Vir and Gilead: how masked T-cell engagers work, why solid cancers are hard, and what the $1.88B deal does not prove.
Posted inLife Science
NIPER Raebareli Training Hub Gives Trials a Promising Boost
NIPER Raebareli will host a clinical research training and certification centre under an MoU with AstraZeneca India. What it covers and what is undisclosed.
Posted inLife Science
Novogene Europe Expands Single-Cell RNA Sequencing Services at Cambridge Omics Centre
The Novogene Europe single-cell RNA sequencing expansion strengthens the company's UK multiomics capabilities, giving academic, biotechnology, and pharmaceutical researchers greater access to advanced transcriptomics services closer to their laboratories. Key…